TODAY'S #BEST #JACKPOT🔥
#SUNPHARMA 🚀 #Futures
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
SUNPHARMA Share Price Discussion
Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Sector: Pharmaceuticals and health care
SUNPHARMA Rating
- ★★
- ★★
- ★★
- ★★
- ★★
3.8/5 (25 Ratings)
SUNPHARMA Share Price *
376.7 +33.15 (9.65%)
* (quote may be delayed)
Find answers to all your questions on live SUNPHARMA message board: Is SUNPHARMA buy or sell? Should I buy SUNPHARMA shares? Why are SUNPHARMA shares falling? Should I invest in SUNPHARMA stock?
You can also check SUNPHARMA share price target recommended by brokerages.
SUNPHARMA Discussion Forum
@walltimes • Reputation: 8,318
Wall Times in SUNPHARMASUNPHARMA APR20 FUTNew trade: Buy SUNPHARMA APR20 FUT, CMP@347.3, ...
384 high
Like
reply
Reply
@TTA • Reputation: 43,172
*SUN PHARMA RS 19.38 CRS NSE BLOCK TRADE; FOR~ 518970 SHARES, AT RS 373.40*
Like
reply
Reply
@ENRITCHANSRAJ • Reputation: -22,626
#ENRICHANSRAJPANDEY in SUNPHARMASUNPHARMA APR20 380 CENew trade: Buy SUNPHARMA APR20 380 CE, CMP@16.1...
SUNPHARMA 💉💉💉FINAL TARGET DONE BOOK HUGE PROFIT AGAIN ♨️♨️♨️♨️
Like
reply
Reply
@ENRITCHANSRAJ • Reputation: -22,626
#ENRICHANSRAJPANDEY in SUNPHARMASUNPHARMA APR20 380 CENew trade: Buy SUNPHARMA APR20 380 CE, CMP@16.1...
Sunpharma new high 21🚀🚀🚀🚀🚀
Like
reply
Reply
@ENRITCHANSRAJ • Reputation: -22,626
#ENRICHANSRAJPANDEY in SUNPHARMASUNPHARMA APR20 380 CENew trade: Buy SUNPHARMA APR20 380 CE, CMP@16.1...
SUNPHARMA 380 CE. MADE A HIGH 19+++ ♨️♨️♨️
Like
reply
Reply
@ENRITCHANSRAJ • Reputation: -22,626
SUNPHARMA APR20 380 CE
1
reply
Reply (3)
Latest replies
Thakyou sir..... today again gatting good profit thank for support
@Candletricks • Reputation: 4,077
"RISKY JACKPOT"
SUNPHARMA BUY @ 347 "CMP"
SL 346.50
TARGET "OPEN"
Like
reply
Reply (1)
Latest replies
NEW HIGH 350++ 🚀
(-600/- RISK PER LOT)😍
RISK 1: 7.70 TIMES PROFIT❤️
4,600/- PROFIT TILL NOW 👍
@researcheducation • Reputation: -55,868
INTRADAY & POSITIONAL
BUY SUNPHARMA
ABOVE 356
STOP LOSS 345
TARGETS 365 375 385 ++
Like
reply
Reply
@100billionclub • Reputation: 2,152
Billion Club in SUNPHARMABUY SUNPHARMA ABV 341
*ONCE EXIT LONG IN SUNPHARMA AT 347. BOOK PROFIT RS. 7,500*
Like
reply
Reply
@100billionclub • Reputation: 2,152
BUY SUNPHARMA ABV 341
Like
reply
Reply (1)
Latest replies
*ONCE EXIT LONG IN SUNPHARMA AT 347. BOOK PROFIT RS. 7,500*
@ashishjshah • Reputation: -723
ASHISH SHAH in SUNPHARMABuy Sun Pharma 330 sl 325 tgt open
444.50
Like
reply
Reply
@tradingfab • Reputation: 895
31-03-20
SUNPHARMA APR PE 330 (Intraday)
only Above @ 25.70
Like
reply
Reply (4)
Latest replies
buy or sell
High 25.90 🔥🔥🚀
High 26.35 🔥🔥💥🚀
High 26.70 🔥🔥🚀🚀
@newsbot • Reputation: 2,570
Sun Pharma share falls 7% on USFDA red flag, but pares all losses
CLSA reiterated buy rating on the stock, though it slashed price target Rs 520 (from Rs 540 per share) on expected lower earnings.
CLSA reiterated buy rating on the stock, though it slashed price target Rs 520 (from Rs 540 per share) on expected lower earnings.
Moneycontrol
Like
reply
Reply
@tradingfab • Reputation: 895
30-03-20 Intraday BUY SUNPHARMA in cash
only Above @ 331
Like
reply
Reply (11)
Latest replies
High 336.80 🔥🔥🚀🚀
Hit 339.70 🔥🔥🚀🚀
hit 342 🔥🚀🚀
selling now
339
@konartradetalk • Reputation: 24,523
💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
SELL SUN PHARMA (HALAOL NEWS) AT THE VERY BEGINING
STRICT STOP LOSS - 345
1ST TARGET - 333
2ND TARGET - 325
3RD TARGET - 318
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose On...
Read more...
Like
reply
Reply
@newsbot • Reputation: 2,570
Stocks in the news: Stocks in the news: SBI, IDBI Bank, Tata Power, Graphite, Lupin, Godawari Power, Sun Pharma
Sun Pharma | SBI | Abott India | HeidelbergCement India | Sobha and aviation stocks are in the news today.
Sun Pharma | SBI | Abott India | HeidelbergCement India | Sobha and aviation stocks are in the news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Coronavirus pandemic | Sun Pharma commits Rs 25 cr worth of drugs, sanitisers to fight COVID-19
"The company is committed to working closely with the governments and relevant stakeholders to ensure that there is uninterrupted supply of medicines," Sun Pharma said in a statement.
"The company is committed to working closely with the governments and relevant stakeholders to ensure that there is uninterrupted supply of medicines," Sun Pharma said in a statement.
Moneycontrol
Like
reply
Reply
@tradingfab • Reputation: 895
27-03-20
SUNPHARMA APR PE 340 (Intraday)
only Above @ 29.60
Like
reply
Reply (3)
Latest replies
High 30 🔥🔥🔥
High 30.35 🔥🔥🔥🚀
31.55 🔥🔥🔥
@newsbot • Reputation: 2,570
CLSA upgrades these pharma stocks and raises target price
CLSA has tweaked its FY20-22 earnings estimates for the sector by 2 percent-3 percent.
CLSA has tweaked its FY20-22 earnings estimates for the sector by 2 percent-3 percent.
Moneycontrol
Like
reply
Reply
@TTA • Reputation: 43,172
*SUNPHARMA RS 20.69 CRS NSE BLOCK TRADE; FOR~ 621263 SHARES, AT RS 333*
Like
reply
Reply
@newsbot • Reputation: 2,570
Coronavirus pandemic | Pharma companies ask sales representatives to work from home
India's largest drug maker Sun Pharma which has field force 9,500 plus covering over 400,000 doctors in every nook and corner of the country said it is encouraging employees in the field globally to work from home.
India's largest drug maker Sun Pharma which has field force 9,500 plus covering over 400,000 doctors in every nook and corner of the country said it is encouraging employees in the field globally to work from home.
Moneycontrol
Like
reply
Reply
@ExpertMahi • Reputation: 1,372
SELL SUNPHARMA BELOW 381 ONLY
SL 386
TAR 378 - 375
Like
reply
Reply (2)
Latest replies
SUNPHARMA METLS 376🏄♀🏄♀
TARG 1 DONE.
START BOOKING... MORNING BREAKFAST DONE🥰
@sridharbalakrishnan • Reputation: 14,918
*Sun Pharmaceutical announces a buyback of Rs 1,700 crore*
17-Mar-2020,
The board of directors of Sun Pharmaceutical Industries has approved share buyback amid broad market sell-off. The board in today’s meeting, approved equity share buyback of Rs 1,700 crore at a maximum pric...
Read more...
1
reply
Reply
@callsanalyst • Reputation: 389
Calls Analyst in SUNPHARMAFor today only 👉Buy at / above: 375.39 Targe...
Buy target achieved successfully
Like
reply
Reply
@newsbot • Reputation: 2,570
Sun Pharma board approves Rs 1,700cr share buy-back offer
In a regulatory filing the company said that the board of directors of the company, at its meeting held on Tuesday has approved the buy-back of its equity shares from the open market at a maximum price of Rs 425 per share for an aggregate maximum amount of up to Rs 1,700 crore.
In a regulatory filing the company said that the board of directors of the company, at its meeting held on Tuesday has approved the buy-back of its equity shares from the open market at a maximum price of Rs 425 per share for an aggregate maximum amount of up to Rs 1,700 crore.
Moneycontrol
Like
reply
Reply
- NewsBotMar 30 5:13 AMSun Pharma share falls 7% on USFDA red flag, but pares all lossesMoneycontrolNewsBotMar 30 1:08 AMStocks in the news: Stocks in the news: SBI, IDBI Bank, Tata Power, Graphite, Lupin, Godawari Power, Sun PharmaMoneycontrolNewsBotMar 28 12:18 PMCoronavirus pandemic | Sun Pharma commits Rs 25 cr worth of drugs, sanitisers to fight COVID-19MoneycontrolNewsBotMar 24 7:43 AMCLSA upgrades these pharma stocks and raises target priceMoneycontrolNewsBotMar 19 10:18 AMCoronavirus pandemic | Pharma companies ask sales representatives to work from homeMoneycontrolNewsBotMar 17 8:28 AMSun Pharma board approves Rs 1,700cr share buy-back offerMoneycontrolNewsBotMar 17 7:48 AM
Sun Pharma share price gains 7% on buyback approvalMoneycontrolNewsBotMar 13 5:08 AM
Sun Pharma share price rises 10% as board to consider share buybackMoneycontrolNewsBotMar 13 1:18 AM
Stocks in the news: Yes Bank, Sun Pharma, Escorts, BPCL, Indian Hotels, Tata SteelMoneycontrolNewsBotMar 12 3:53 AM
Sun Pharma board to consider share buyback plan next weekMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.